Travel Vaccines Market Size, Share & Trends Analysis Report By Composition (Mono Vaccines, Combination Vaccines), By Disease (Hepatitis A , DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, Others), By Application (Domestic Travel, Outbound Travel), By End-User (Adult Vaccines, Pediatric Vaccines) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Market Overview

The global travel vaccines market size was valued at USD 4.8 billion in 2025 and is projected to grow from USD 5.26 billion in 2026 to USD 10.86 billion by 2034, registering a CAGR of 9.5% during the forecast period from 2026 to 2034. North America dominated the travel vaccines market with a market share of 36% in 2025.

Travel vaccines, often called travel immunizations or travel vaccinations, are injections administered to persons before their travel to particular regions or countries to safeguard them against specific diseases that may be widespread in such locations. The objective is to mitigate the transmission of contagious illnesses and ensure the well-being of both travelers and the indigenous people. The selection of vaccines advised or mandated for travel is contingent upon several criteria, such as the travel location, the length of the journey, the age and health condition of the traveler, and their prior immunization record.

The market expansion is anticipated to be driven by a rise in travel-related disorders. Traveling is frequently linked to increased health hazards, particularly contagious illnesses. Consequently, the increasing prevalence of diseases associated with travel will result in more significant investments in the worldwide Travel Vaccines Market to enhance the development of more efficient vaccines.

Segmental Analysis

The global travel vaccines market is segmented based on composition, disease type, end-user, and application.

Based on the composition, the market is segmented into Mono Vaccines and Combination Vaccines.

Combination vaccines dominated in 2023. Combination vaccines provide the advantage of safeguarding against many diseases by a solitary injection. Common combination vaccines include those that offer protection against hepatitis A and B and typhoid. Combination vaccinations offer a significant benefit by efficiently providing complete protection, simplifying the vaccination process for tourists. This convenience is beautiful for persons who intend to travel to areas with different disease risks, thereby minimizing the number of vaccinations needed. The category of combination vaccines is experiencing growth as a result of a higher demand for simplified vaccination schedules and improved adherence among travelers looking for a single-shot solution for their healthcare requirements.

The mono-vaccine segment is the fastest growing. Mono vaccines are composed of separate vaccines that specifically target particular diseases. These vaccines are specifically formulated to offer immunity against a single pathogen, such as hepatitis A, hepatitis B, or typhoid. Monovalent vaccinations are frequently advised for travelers visiting places with an exceptionally elevated risk of a particular disease. They provide focused protection, enabling travelers to tailor their immunization schedule to their destination and personal health requirements.

Request Customizationto receive a tailored report.

Based on disease type, the market is segmented into Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and Others.

The hepatitis A segment dominated in 2023. The hepatitis A category will have the highest market share throughout the projection period. Hepatitis A is commonly spread by food and water that has been polluted. Individuals who visit areas with insufficient sanitary facilities are more likely to ingest contaminated items, thus necessitating the Hepatitis A vaccination as a crucial measure for protection.

The DPT vaccines segment is the fastest growing. DPT vaccines, which provide immunity against diphtheria, pertussis (whooping cough), and tetanus, constitute a significant portion of the travel vaccines industry. Although these diseases are not limited to hazards associated with travel, they are included in specific international immunization recommendations. Tetanus may represent a risk to tourists encountering infected wounds on their trips. Thus, DPT immunizations guarantee complete protection against these avoidable illnesses, even while traveling.

The yellow fever vaccine segment is the second largest. Yellow fever vaccinations are designed to prevent yellow fever, a viral disease transmitted by mosquitoes, and are common in specific tropical areas. Travelers visiting areas in Africa and South America where yellow fever is frequently found must provide evidence of vaccination to enter. The yellow fever segment in the travel vaccines market caters to visitors who intend to visit these high-risk regions and must comply with international health laws.

By application, the market is segmented into Domestic Travel and Outbound Travel.

The outbound travel segment dominated in 2023. Outgoing travelers frequently explore areas with diverse temperatures, habitats, and health hazards. Travelers may encounter uncommon diseases in their home countries, requiring particular travel vaccines to defend against infections peculiar to specific regions. Outgoing travelers have the opportunity to visit nations that have different degrees of healthcare infrastructure. Disparities in access to medical facilities and healthcare services might vary greatly, underscoring the importance of preventive measures, such as immunizations, in preserving health while traveling internationally.

The domestic travel segment is the fastest growing. Although overseas travel frequently receives more focus, domestic travel substantially drives the need for immunizations. Individuals journeying within their nation may encounter varying health hazards contingent upon the climate, topography, and incidence of diseases in different regions. Thus, those doing domestic excursions may need particular vaccines to safeguard against endemic diseases like tick-borne encephalitis or Lyme disease. Moreover, business travelers and tourists exploring domestic destinations also drive the need for travel vaccinations. This highlights the significance of addressing the travel needs of both international and domestic travelers in the market.

The market is segmented into adult and pediatric vaccines based on end-users.

The adult vaccines segment dominated in 2023. Adult vaccines are pharmaceutical substances advised for individuals who have reached the age of 18 or above. These compounds protect against infectious diseases that can be acquired at any stage of life and can have severe repercussions for adulthood. Common adult vaccines include tetanus, diphtheria, pertussis (Tdap), influenza, pneumococcal illness, hepatitis A and B, and shingles. As global travel activities continue to expand, there will be a higher demand for adult vaccines. This will result in the expansion of the adult vaccine sector in the market throughout the forecast period.

The pediatric vaccines segment is the fastest growing. These vaccines are specifically formulated to safeguard children from measles, mumps, rubella, polio, hepatitis A and B, typhoid, and yellow fever. These diseases can be easily transmitted through direct contact with infected individuals or contaminated surfaces and can cause severe illness or even fatalities in some instances. Pediatrics not only safeguards the well-being of individual children but also plays a crucial role in preventing the transmission of contagious diseases and safeguarding public health. The extensive advantages of pediatric medicines will stimulate their utilization and contribute to the expansion of the pediatric vaccinations sector in the global market during the projected timeframe.

Speak to an Analystto discuss market opportunities.

Regional Analysis

North America Dominates the Global Market

The global travel vaccines market analysis is conducted across North America, Europe, Asia-Pacific, the Middle East and Africa, and Latin America.

North America is the most significant global travel vaccines market shareholder and is estimated to grow at a CAGR of 9.1% over the forecast period. North America will maintain its market dominance during the predicted period. The Pan American Health Organization (PAHO), a government entity, exerts significant influence on the regional market by establishing recommended immunization schedules for vaccination. The primary vaccinations marketed in North America included BOOSTRIX, INFANRIX, Pediarix, BEXSERO, MENVEO, and influenza vaccines. In affluent countries of the region, infectious and non-infectious diseases have been steadily rising in recent years. For example, in the United States, influenza significantly rises from November and remains consistently high for many weeks from January to February annually.

Furthermore, the region is experiencing a rise in the availability of vaccines for these diseases and an increasing number of efforts to promote awareness about immunization programs. Moreover, those applying for an immigration visa in the United States must fulfill the vaccine prerequisites for specific diseases. The World Health Organization (WHO) and CDC advise that US travelers receive vaccinations against rabies, hepatitis A and B, measles, mumps and rubella, diphtheria, pneumonia, and influenza. Therefore, the increasing need for immunization before traveling to nations in the region is anticipated to promote the expansion of the market in North America throughout the projected timeframe.

Unlock Regional Insightsto access country-level data, & regional trends.

Europe is anticipated to exhibit a CAGR of 9.8% over the forecast period. Due to their wide variety of locations and many international travelers, European countries show a substantial need for travel immunizations. The European Union is formulating rules for travelers, advising on vaccines according to the destination and health background. European tourists exhibit a proactive approach in seeking pre-travel healthcare advice, which has led to expanding the business in the region.

The Asia-Pacific market proliferates due to increased outbound tourism and business travel. With the growth of economies in the region, an increasing number of individuals now have both the financial resources and the inclination to travel to foreign countries. This leads to increased awareness of travel-related health concerns, driving the need for travel vaccines. In addition, several countries are gaining popularity as tourist hotspots, resulting in a rise in the number of incoming passengers needing vaccination.

List of Key and Emerging Players in Travel Vaccines Market